AABB to Join Roundtable Discussion on Expanding CGT Access During ISCT 2026

Jeff Wren, MBA, CABP, AABB’s vice president of biotherapies, will explore strategies to safely and effectively scale cell and gene therapies (CGTs) beyond centers of excellence during a roundtable session at ISCT 2026 in Dublin, Ireland.

The roundtable discussion will take place 1-2 p.m. Irish Standard Time on Wednesday, May 6, and will focus on the operational, regulatory and infrastructure considerations required to broaden patient access while maintaining safety and quality.

Wren will be joined at the meeting by Christina Celluzzi, PhD, MS, CABP(H), AABB’s director of biotherapies. Attendees interested in connecting with AABB’s during the meeting can visit AABB’s virtual booth or reach out in advance to schedule a conversation.